PCA SKIN Launches Triple Exfoliation Peel Pads for Home Use
SCOTTSDALE, Ariz., June 1, 2026 PCA SKINĀ®, a globally recognized leader in professional skincare and chemical peel innovation, has...
Alzheimerās Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
SCOTTSDALE, Ariz., June 1, 2026 PCA SKINĀ®, a globally recognized leader in professional skincare and chemical peel innovation, has...
IRVING, Texas, April 9, 2026 Revision SkincareĀ® has announced the publication of two peer-reviewed clinical studies in the Journal...
NEW DELHI, India, April 3, 2026 Kama Ayurveda has announced the launch of its Sandanya anti-blemish skincare collection, marking...
ZUG, Switzerland, January 29, 2026 ā Galderma, the global pure-play dermatology leader, has unveiled āWake Up To RestylaneĀ®ā, a...
